Access cutting-edge chronic inflammatory demyelinating polyneuropathy treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.
Access chronic inflammatory demyelinating polyneuropathy specialists in New Haven at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic inflammatory demyelinating polyneuropathy treatment provided free
This is a Phase 2b study to evaluate the efficacy and safety of IMVT-1402 in adults with CIDP.
Sponsor: Immunovant Sciences GmbH
Check if you qualify for this chronic inflammatory demyelinating polyneuropathy clinical trial in New Haven, CT
If you're searching for chronic inflammatory demyelinating polyneuropathy treatment options in New Haven, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.